Investigating the frequency of SHV gene encoding ESBL in E.coli strains isolated from urine samples of patients who were referred to hospitals and medical centers in Semnan city

authors:

avatar Alireza Shabani , avatar Ali Akbar Shaebani , * , avatar Reza Nasr , avatar Maryam Ardakanian , avatar Sima Ravai , avatar Alireza Afghan Pertabi , avatar Hossein Anani , avatar Hoda Shabani , avatar Ali Abu Zari , avatar Majid Qurbani , avatar Fateme Mehrjo


how to cite: Shabani A, Shaebani A A, Nasr R, Ardakanian M, Ravai S, et al. Investigating the frequency of SHV gene encoding ESBL in E.coli strains isolated from urine samples of patients who were referred to hospitals and medical centers in Semnan city. koomesh. 2023;25(6):e152865. 

Abstract

Introduction: Numerous reports indicate the spread of multiple drug resistances through different types of Extended Spectrum Beta Lactamase (ESBL), including enzymes resulting from SHV gene expression in different parts of the world, which is one of the major medical and therapeutic problems. Nowadays, investigating the role of Escherichia coli bacteria in various infections, including hospital infections, and the amount of use of different antibiotics in treatment, considering the increasing resistance of bacteria causing infection to antibiotics, is a necessity. The purpose of this research project was to investigate the prevalence of the SHV gene as one of the genes encoding ESBL in infectious bacteria including E. coli strains. Materials and Methods: Sampling and isolation of Escherichia coli collected from clients suspected of urinary tract infection using standard methods and antibiogram test using disc-diffusion method were performed on them. To identify strains producing broad-spectrum beta-lactamases (ESBLs), nitrocephene-resistant isolates rechecked with the combined disc method to definitively detect the production of broad-spectrum beta-lactamase enzymes (ESBLs) with the use of pairs of ceftazidime, cefotaxime, cefotaxime, and ceftazidime antibiotic discs with and without clavulanic acid purchased from British Mast Company were tested. By extracting DNA from them using specific primers designed, evaluated, and prepared for the SHV gene, and performing PCR, the presence or absence of the SHV gene in the above strains was evaluated. Results: E. coli strains were isolated from 151 urinary samples (37.75)%. Isolates resistant to nitrocephene were considered as possible strains producing extended-spectrum beta-lactamases (ESBLs), the result of the confirmatory phenotypic test on probable positive (+) ESBL strains, in 33 cases (67.47) % of them were positive. By performing PCR using a pair of specific primers designed and prepared to detect and identify the SHV gene, the result of this test was also positive in 9 cases (72.72) % of them. Conclusion: Using molecular methods along with phenotypic methods to accurately diagnose infectious agents, even their VBNC (viable but non-culturable) forms, and resistance genes can make the effectiveness of "molecular epidemiology" methods in tracking and increasing the fight against infections, including hospital infections.

References

  • 1.

    Mansor MR, Ali Hasan Kashkool D, Safaa Abd Al-Ameer S, Akeel Al-Hasan B, Almulla AF. Molecular detection of bla(SHV-la) gene in Klebsiella pneumonia isolated from urinary tract infections, Najaf, Iraq. Arch Razi Inst 2022; 77: 1181-1184.

  • 2.

    Amir Mozaffari N, Forouhesh Tehrani H, Tavaf Langeroodi Z, Abdullahi A. A survey of drug resistance due to extended spectrum beta lactamases (ESBLs) in escherichia coli strains isolated from hospitalized patients. Razi J Med Sci 2008; 15: 39-46.

  • 3.

    Kazemian H, Heidari H, Ghanavati R, Ghafourian S, Yazdani F, Sadeghifard N, et al. Phenotypic and genotypic characterization of ESBL-, AmpC-, and carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates. Med Princ Pract 2019; 28: 547-551.

  • 4.

    Tafti A, Zandi H, Vakli M, Mousavi SM, Zarei M. Frequency of -lactamase and metallo--lactamase in Pseudomonas aeruginosa strains isolated from burn wounds in Yazd burn hospital during 2011-2012. Koomesh 2014; 18: 167-174. (Persian).

  • 5.

    Shahcheraghi F, Noveiri H, Nasiri S. Detection of bla TEM and bla SHVgenes among clinical isolates of E. coli from Tehran hospitals. Iran J Med Microbiol 2007; 1: 1-8.

  • 6.

    Miller R, Carson J, Dalsgaard I, Gaunt P, Gieseker C, Hawke J, Reimschuessel R, Smith P, Somsiri T, Wu C. CLSI performance standards for antimicrobial susceptibility testing of bacteria isoloated from aquatic animals; second information supplement. CLSI document VET03/VET04-S2. Book Chapter 2014; 56.

  • 7.

    Bush K, Jacoby GA. Updated Functional Classification of -Lactamases. Antimicrob Agents Chemother 2010; 969-976.

  • 8.

    Delfani S, Kalantar-Neyestanaki D, Godarzi G, Soroush S, Rezaei F. Characterization co-existence of ESBLs, AmpC and MBLs in Escherichia coli and Klebsiella pneumoniae isolates from Khorramabad Hospitals. Yafteh 2020; 22: 58-67.

  • 9.

    Shahcheraghi F, NS, Noiri H. Investigation the presence of blaSHV and blaTEM beta-lactamase genes. In antibiotic-resistant Escherichia coli strains isolated from clinical samples from Tehran hospitals. Iran J Med Microbiol 1386; 1: 1-8. (Persian).

  • 10.

    Tonekabony N, Izadi Amoli R, Gholami A, Oskoueiyan R. Prevalence of SHV gene and antibiotic resistance of extended-spectrum -lactamase-producing Escherichia coli strains isolated from abattoir wastewater in Mazandaran Province, north of Iran. Caspian J Environ Sci 2021; 19: 11-17. (Persian).

  • 11.

    Behrouzi A, Rahbar M, Vand Yousefi J. The prevalence of Extended-Spectrum -lactamase (ESBLs) producing Klebsiella pneumonia and Eschrrichia coli isolated in Milad hospital of Tehran in 2010. Iran J Med Microbiol 2010; 4: 36-41. (Persian).

  • 12.

    Yazdi M, Nazemi A. Prevaaence of SHV/CTX-M/TEM beta lactamase resistance genes in Escherichia coli isolated from UTI in Tehran city. 2001. (Persian).

  • 13.

    Shabani A, Ebrahimi VM, Agaei S, Nasr R. A survey frequency of TEM-1 gene in E. coli strains isolated from clinical specimens in Damqan city. 2012. (Persian).

  • 14.

    Alipour M, Jafari A. Evaluation of the prevalence of blaSHV, blaTEM, and blaCTX Genes in Escherichia coli isolated from urinary tract infections. Avicenna J Clin Microbiol Infect 2019; 6: 83-87.##https://doi.org/10.34172/ajcmi.2019.15.

  • 15.

    Ghenea AE, Zlatian OM, Cristea OM, Ungureanu A, Mititelu RR, Balasoiu AT, et al. TEM,CTX-M,SHV genes in ESBL-Producing escherichia coli and Klebsiella pneumoniae isolated from clinical samples in a county clinical emergency hospital romania-predominance of CTX-M-15. Antibiotics (Basel) 2022; 11.

  • 16.

    Samiei Abianeh H, Nazarian S, Hajizadeh A, Kordbach E. Expression, purification, and immunization of a chimeric protein containing immunogenic regions of flagellin and intimin proteins against E. coli O157: H7. Koomesh 2022; 24: 717-726. (Persian).

  • 17.

    Giske CG, Turnidge J, Cantn R, Kahlmeter G. Update from the European committee on antimicrobial susceptibility testing (EUCAST). J Clin Microbiol 2022; 60: e0027621.

  • 18.

    Ahadi H, Attaran B, Mansour Ghanaie R, Ganji L, Fallah F, Karimi A, et al. Molecular investigation of Campylobacter spp. and salmonella infection in children with community acquired diarrhea. Koomesh 2022; 24: 684-690. (Persian).